Abstract:Background: Multiple sclerosis (MS) is a chronic autoimmune disease damaging the central nervous system. Diminished inflammatory disease activities (DAs) as people with MS (pwMS) age justified randomized clinical trials assessing disease-modifying therapy (DMT) discontinuation in older pwMS given the concern for risks outweighing benefits. Objective: This study aims to examine the effect of age on DAs and the peripheral production of Myelin Basic Protein (MBP)-driven cytokine response in pwMS. Methods: We included the clinical data of 368 adult pwMS between 2017 and 2021 who enrolled in a clinic-based prospective cohort. From 80 participants, we isolated fresh peripheral blood mononuclear cells (PBMCs) and cultured with 50μg/ml of MBP for 24 hours. We assayed cell culture supernatants for interleukin 17 (IL-17) and interferon gamma (IFN-gamma;) using Enzyme-Linked Immunosorbent Assay and a subset of the supernatant samples using a commercial human cytokine/chemokine array. We examined the associations between age and annualized relapse rate (ARR) as well as between age and MBP-stimulated cytokine production (by cultured PBMC) using covariate-adjusted linear regressions. We performed mediation analyses to determine the extent to which MBP-driven cytokine responses drive the association between age and ARR. Results: Among the 386 pwMS (mean age 53.1±12.6 years, 79.9% women, 92.1% non-Hispanic White), ARR declined with age (β=-0.003, p<0.001). Among the 80 pwMS whose cultured PBMCs underwent ex vivo MBP stimulation, IL-17 production declined with age in women (β=-0.27, p=0.04) but not men (β=-0.1, p=0.73). MBP-driven IL-17 response partially mediated the association between older age and lower ARR (24.7% in women, 15.3% in men). Further, older pwMS (≥50 years) had significantly lower (IL-4, MCP-2, MCP-3, PDGF-AA, PDGF-AB/BB) and higher (Fractalkine, MDC) concentrations of several cytokines when compared to younger pwMS (<50 years). These cytokines affected the association between age and ARR in different ways, with some (MCP-2 and MDC) mediating the effect of age on ARR, while the others counteracting the effect of age on ARR. Conclusion: This study suggests some of the potential biological mechanisms driving aging-dependent decline in MS inflammatory DA.

Identification of crucial inflammaging related risk factors in multiple sclerosis

Integrated bioinformatic analysis and experimental validation for exploring the key molecular of brain inflammaging

Identifying Diagnostic Markers and Constructing Predictive Models for Oxidative Stress in Multiple Sclerosis

337 Cellular senescence contributes to inflammation and disease progression in an animal model of multiple sclerosis

Inflammation and aging: signaling pathways and intervention therapies

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics

Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis

Cognitive frailty predicting death and disability in Chinese elderly

Integration of Genetic and Immune Infiltration Insights into Data Mining of Multiple Sclerosis Pathogenesis

Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions

Systemic Inflammation and the Risk of Multiple System Atrophy: A Prospective Cohort Study

A Combined Aging and Immune Prognostic Signature Predict Prognosis and Responsiveness to Immunotherapy in Melanoma

Integrating Genetic and Proteomic Data to Elucidate the Association Between Immune System and Blood-Brain Barrier Dysfunction with Multiple Sclerosis Risk and Severity

An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging

Aging-dependent Change in Th17 and Cytokine Response in Multiple Sclerosis

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Biologically informed machine learning modeling of immune cells to reveal physiological and pathological aging process

Connecting aging biology and inflammation in the omics era

Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis

Autophagy in Multiple Sclerosis: Phagocytosis and Autophagy of Oligodendrocyte Precursor Cells